HRQoL	Health-related quality of life
PROs	Patient-reported outcomes
RCTs	Randomized controlled trials
CONSORT-PRO	Consolidated Standards of Reporting Trials—Patient-Reported Outcomes (Extension)
EORTC	European Organisation for Research and Treatment of Cancer
EORTC QLQ-C30	European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30
EORTC QLQ-EN24	European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Endometrial Cancer Module
EQ-5D-5L	EuroQol 5-Dimension 5-Level Questionnaire
OS	Overall survival
TCGA	The Cancer Genome Atlas
PFS	Progression-free survival
PARP	Poly(ADP-ribose) polymerase
QoL	Quality of life
SPIRIT-PRO	Standard Protocol Items: Recommendations for Interventional Trials—Patient-Reported Outcomes Extension
PRISMA	Preferred Reporting Items for Systematic reviews and Meta-Analyses
ESMO	European Society for Medical Oncology
ASCO	American Society of Clinical Oncology
SGO	Society of Gynecologic Oncology
ESGO	European Society of Gynecological Oncology
IGCS	International Gynecologic Cancer Society
PROSPERO	International Prospective Register of Systematic Reviews
SPSS	Statistical Package for the Social Sciences
CT	Carboplatin-Paclitaxel
Q3W	Every 3 weeks
FACT	Functional Assessment of Cancer Therapy
FACT-PWB	Physical Well-Being
FACT-FWB	Functional Well-Being
FACT-En TOI	Endometrial Trial Outcome
FACT/GOG-Ntx4	Gynecologic Oncology Group—Neurotoxicity 4-item scale
PROMIS	Patient-Reported Outcomes Measurement Information System
GHS/QoL	Global Health Status/Quality of Life (the mean of Q29 and Q30 of the EORTC QLQ-C30 questionnaire)
FACT/item GP5	“I am bothered by side effects of treatment”
PGIS	Patient Global Impression of Severity
PRO-CTCAE	Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
PGIC	Patient Global Impression of Change
PGI-TT	Patient Global Impression of Targeted Therapy
PGI-BR	Patient Global Impression of Benefit–Risk
IF	Impact factor
CSO	Common Sense Oncology
SISAQOL	Setting International Standards in Analyses of Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Trials
ESMO-MCBS	European Society for Medical Oncology Magnitude of Clinical Benefit Scale